Field cancerization in the intestinal epithelium of patients with Crohn's ileocolitis

Gastroenterology

Volumn 142, Issue 4, 2012, Pages

  Galandiuk, Susan ^a,b,c   Rodriguezjusto, Manuel ^d   Jeffery, Rosemary ^a   Nicholson, Anna M ^b   Cheng, Yong ^a,f   Oukrif, Dahmane ^d   Elia, George ^b   Leedham, Simon J ^e   McDonald, Stuart A C ^a,b   Wright, Nicholas A ^a,b   Graham, Trevor A ^a,g  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clonal Ordering; CRC; Inflammatory Bowel Disease; Oncogene; Tumor Progression

Indexed keywords

BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CARCINOGENESIS; CELL CLONE; CELL GROWTH; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CRYPT CELL; DISEASE ASSOCIATION; EPITHELIUM DYSPLASIA; FEMALE; FIELD CANCERIZATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC PROCEDURES; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CANCER; INTESTINE CELL; INTESTINE EPITHELIUM; INTESTINE TUMOR; MALE; MICRODISSECTION; ONCOGENE K RAS; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; SCHOOL CHILD; TISSUE SECTION;

EID: 84859393237     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.12.004     Document Type: Article

References (49)

1. M.G. Laukoetter, R. Mennigen, C.M. Hannig Intestinal cancer risk in Crohn's disease: a meta-analysis J Gastrointest Surg 15 2011 576 583
2. K. Hemminki, X. Li, J. Sundquist Cancer risks in Crohn disease patients Ann Oncol 20 2009 574 580
3. A.C. von Roon, G. Reese, J. Teare The risk of cancer in patients with Crohn's disease Dis Colon Rectum 50 2007 839 855
4. C. Canavan, K.R. Abrams, J. Mayberry Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease Aliment Pharmacol Ther 23 2006 1097 1104
5. S.N. Gyde, P. Prior, J.C. Macartney Malignancy in Crohn's disease Gut 21 1980 1024 1029
6. W.R. Connell, J.P. Sheffield, M.A. Kamm Lower gastrointestinal malignancy in Crohn's disease Gut 35 1994 347 352
7. M.B. Ribeiro, A.J. Greenstein, D.B. Sachar Colorectal adenocarcinoma in Crohn's disease Ann Surg 223 1996 186 193
8. D.P. Slaughter, H.W. Southwick, W. Smejkal Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin Cancer 6 1953 963 968
9. B.J.M. Braakhuis, M.P. Tabor, J.A. Kummer A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications Cancer Res 63 2003 1727 1730
10. T. Ushijima Epigenetic field for cancerization J Biochem Mol Biol 40 2007 142 150
11. R. McCombs A hypothesis on the causation of cancer Science 72 1930 423 424
12. P.C. Nowell The clonal evolution of tumor cell populations Science 194 1976 23 28
13. W.A. Franklin, A.F. Gazdar, J. Haney Widely dispersed p53 mutation in respiratory epithelium A novel mechanism for field carcinogenesis J Clin Invest 100 1997 2133 2137
14. S.J. Leedham, T.A. Graham, D. Oukrif Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia Gastroenterology 136 2009 543550.e6
15. K. Nosho, S. Kure, N. Irahara A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers Gastroenterology 137 2009 1609 1620 e13
16. C. Hafner, A. Toll, A. Fernandez-Casado Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors Proc Natl Acad Sci U S A 107 2010 20780 20785
17. G.T. Chung, V. Sundaresan, P. Hasleton Clonal evolution of lung tumors Cancer Res 56 1996 1609 1614
18. F.A. Farraye, R.D. Odze, J. Eaden AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease Gastroenterology 138 2010 738 745
19. S.R. Cairns, J.H. Scholefield, R.J. Steele Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002) Gut 59 2010 666 689
20. T. Ullman, R. Odze, F.A. Farraye Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon Inflamm Bowel Dis 15 2009 630 638
21. S.E. Kern, M. Redston, A.B. Seymour Molecular genetic profiles of colitis-associated neoplasms Gastroenterology 107 1994 420 428
22. A. Rashid, S.R. Hamilton Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine Gastroenterology 113 1997 127 135
23. S.P. Hussain, P. Amstad, K. Raja Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease Cancer Res 60 2000 3333 3337
24. A.J. Rowan, H. Lamlum, M. Ilyas APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits." Proc Natl Acad Sci U S A 97 2000 3352 3357
25. A.T. Hoque, S.A. Hahn, M. Schutte DPC4 gene mutation in colitis associated neoplasia Gut 40 1997 120 122
26. T.A. Graham, N.A. Wright Investigating the fixation and spread of mutations in the gastrointestinal epithelium Future Oncol 4 2008 825 839
27. C. Thirlwell, O.C.C. Will, E. Domingo Clonality assessment and clonal ordering of individual neoplastic crypts shows polyclonality of colorectal adenomas Gastroenterology 138 2010 1441 1454 1454.e17
28. C.C. Maley, P.C. Galipeau, X. Li Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus Cancer Res 64 2004 3414 3427
29. J.G. Stone, I.P. Tomlinson, R.S. Houlston Optimising methods for determining RER status in colorectal cancers Cancer Lett 149 2000 15 20
30. A. Petitjean, E. Mathe, S. Kato Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database Hum Mutat 28 2007 622 629
31. L.J. Prevo, C.A. Sanchez, P.C. Galipeau p53-mutant clones and field effects in Barrett's esophagus Cancer Res 59 1999 4784 4787
32. J.F. Flejou, V. Gratio, F. Muzeau p53 abnormalities in adenocarcinoma of the gastric cardia and antrum Mol Pathol 52 1999 263 268
33. T. Yoshida, T. Mikami, H. Mitomi Diverse p53 alterations in ulcerative colitis-associated low-grade dysplasia: full-length gene sequencing in microdissected single crypts J Pathol 199 2003 166 175
34. L.C. Greaves, S.L. Preston, P.J. Tadrous Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission Proc Natl Acad Sci U S A 103 2006 714 719
35. L. Gutierrez-Gonzalez, M. Deheragoda, G. Elia Analysis of the clonal architecture of the human small intestinal epithelium establishes a common stem cell for all lineages and reveals a mechanism for the fixation and spread of mutations J Pathol 217 2009 489 496
36. H. Cheng, M. Bjerknes, J. Amar Crypt production in normal and diseased human colonic epithelium Anat Rec 216 1986 44 48
37. D.L. Chao, J.T. Eck, D.E. Brash Preneoplastic lesion growth driven by the death of adjacent normal stem cells Proc Natl Acad Sci U S A 105 2008 15034 15039
38. T. Nystul, A. Spradling An epithelial niche in the Drosophila ovary undergoes long-range stem cell replacement Cell Stem Cell 1 2007 277 285
39. S. Kato, S.-Y. Han, W. Liu Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis Proc Natl Acad Sci U S A 100 2003 8424 8429
40. E. Moreno Is cell competition relevant to cancer? Nat Rev Cancer 8 2008 141 147
41. T.A. Brentnall, D.A. Crispin, P.S. Rabinovitch Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis Gastroenterology 107 1994 369 378
42. G.C. Burmer, P.S. Rabinovitch, R.C. Haggitt Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele Gastroenterology 103 1992 1602 1610
43. R. Chen, P.S. Rabinovitch, D.A. Crispin DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free Am J Pathol 162 2003 665 672
44. D.R. Williams, J.A. Coller, M.L. Corman Anal complications in Crohn's disease Dis Colon Rectum 24 1981 22 24
45. M. Kedinger, O. Lefebvre, I. Duluc Cellular and molecular partners involved in gut morphogenesis and differentiation Philos Trans R Soc Lond B Biol Sci 353 1998 847 856
46. F. Benahmed, I. Gross, S.J. Gaunt Multiple regulatory regions control the complex expression pattern of the mouse Cdx2 homeobox gene Gastroenterology 135 2008 1238 1247 1247 e13
47. J.G. Stone, I.P. Tomlinson, R.S. Houlston Optimising methods for determining RER status in colorectal cancers Cancer Lett 149 2000 15 20
48. S.J. Leedham, T.A. Graham, D. Oukrif Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia Gastroenterology 136 2009 543550.e6
49. A. Buhmeida, A. Algars, R. Ristamaki DNA image cytometry is a useful adjunct tool in the prediction of disease outcome in patients with stage II and stage III colorectal cancer Oncology 70 2006 427 437